YahooAugust 28, 2026 at 2:44 PM NY2 Months Ago

BioNTech Stock Falls on Cancer Vaccine Setback Days After Moderna’s Big Win

BNTXBiontech SE

BioNTech says it’s ending a Phase 2 trial for its investigational personalized mRNA cancer vaccine. It was being tested to treat colorectal cancer.

What This Story Means

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo